Anne Searls De Groot

Anne Searls De Groot's AcademicInfluence.com Rankings

Biology

#14439

World Rank

#18193

Historical Rank

#2849

USA Rank

Immunology

#1001

World Rank

#1025

Historical Rank

#105

USA Rank

biology Degrees

Download Badge

Biology

Why Is Anne Searls De Groot Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Anne Searls De Groot is a physician, immunologist and entrepreneur. She is the co-founder and CEO/CSO of the immunoinformatics company EpiVax. She is actively involved in graduate teaching at the Center for Vaccines and Immunology and guides the scientific research program in her laboratory at EpiVax.

(See a Problem?)

Anne Searls De Groot's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Immunogenicity of protein therapeutics. (2007) (457)
Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes". (2008) (367)
T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation. (2013) (201)
From genome to vaccine: in silico predictions, ex vivo verification. (2001) (177)
Reducing risk, improving outcomes: bioengineering less immunogenic protein therapeutics. (2009) (176)
Immuno‐informatics: Mining genomes for vaccine components (2002) (170)
Two novel T cell epitope prediction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences. (1995) (160)
Emerging Vaccine Informatics (2011) (147)
Clinical validation of the "in silico" prediction of immunogenicity of a human recombinant therapeutic protein. (2007) (127)
Immunomics: discovering new targets for vaccines and therapeutics. (2006) (113)
Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-2009 conventional influenza vaccine. (2009) (111)
An interactive Web site providing major histocompatibility ligand predictions: application to HIV research. (1997) (104)
Prediction of well-conserved HIV-1 ligands using a matrix-based algorithm, EpiMatrix. (1998) (101)
Prediction of immunogenicity: in silico paradigms, ex vivo and in vivo correlates. (2008) (99)
From genome to vaccine--new immunoinformatics tools for vaccine design. (2004) (97)
Prediction of immunogenicity for therapeutic proteins: state of the art. (2007) (96)
T cell epitope: Friend or Foe? Immunogenicity of biologics in context☆ (2009) (96)
HIV vaccine development by computer assisted design: the GAIA vaccine. (2005) (94)
Immunomics: discovering new targets for vaccines and therapeutics (2006) (90)
Developing an epitope-driven tuberculosis (TB) vaccine. (2005) (87)
Tregitope update: mechanism of action parallels IVIg. (2013) (82)
Mapping cross-clade HIV-1 vaccine epitopes using a bioinformatics approach. (2003) (81)
iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines (2015) (77)
Genome-derived vaccines (2004) (75)
A Method for Individualizing the Prediction of Immunogenicity of Protein Vaccines and Biologic Therapeutics: Individualized T Cell Epitope Measure (iTEM) (2010) (74)
HelicoVax: epitope-based therapeutic Helicobacter pylori vaccination in a mouse model. (2011) (73)
Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine. (2007) (71)
Effect of HLA DR epitope de-immunization of Factor VIII in vitro and in vivo. (2012) (68)
In Vitro and In Vivo Studies of IgG-derived Treg Epitopes (Tregitopes): A Promising New Tool for Tolerance Induction and Treatment of Autoimmunity (2012) (68)
Coupling sensitive in vitro and in silico techniques to assess cross-reactive CD4(+) T cells against the swine-origin H1N1 influenza virus. (2011) (66)
A Cross-Sectional Study to Assess HPV Knowledge and HPV Vaccine Acceptability in Mali (2013) (64)
The two-faced T cell epitope: examining the host-microbe interface with JanusMatrix (P4399) (2013) (63)
Bioinformatics tools for identifying class I-restricted epitopes. (2003) (58)
VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response alone. (2011) (58)
In silico-accelerated identification of conserved and immunogenic variola/vaccinia T-cell epitopes. (2009) (57)
Human T cell recognition of polymorphic epitopes from malaria circumsporozoite protein. (1989) (56)
An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected Thais. (2001) (56)
Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools (2020) (55)
Differential non-responsiveness in humans of candidate Plasmodium falciparum vaccine antigens. (1989) (54)
Engineering immunogenic consensus T helper epitopes for a cross-clade HIV vaccine. (2004) (53)
Low immunogenicity predicted for emerging avian-origin H7N9 (2013) (53)
HLA-A2-Restricted CD8+-Cytotoxic-T-Cell Responses to Novel Epitopes in Mycobacterium tuberculosis Superoxide Dismutase, Alanine Dehydrogenase, and Glutamine Synthetase (2004) (53)
Epitope-Based Immunome-Derived Vaccines: A Strategy for Improved Design and Safety (2008) (53)
The two-faced T cell epitope (2013) (51)
Identification of immunogenic HLA-B7 "Achilles' heel" epitopes within highly conserved regions of HIV. (2008) (49)
A call to cellular & humoral arms: Enlisting cognate T cell help to develop broad-spectrum vaccines against influenza A (2008) (47)
Can we prevent immunogenicity of human protein drugs? (2009) (45)
CHOPPI: A Web Tool for the Analysis of Immunogenicity Risk from Host Cell Proteins in CHO-Based Protein Production (2014) (44)
Aspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinoma. (2015) (43)
Epitope-driven TB vaccine development: a streamlined approach using immuno-informatics, ELISpot assays, and HLA transgenic mice. (2007) (43)
Application of IgG-Derived Natural Treg Epitopes (IgG Tregitopes) to Antigen-Specific Tolerance Induction in a Murine Model of Type 1 Diabetes (2013) (43)
Epitope-based vaccination against pneumonic tularemia. (2009) (42)
Prediction of HIV peptide epitopes by a novel algorithm. (1996) (42)
Thyrotropin receptor epitopes and their relation to histocompatibility leukocyte antigen-DR molecules in Graves' disease. (2006) (41)
Integrated assessment of predicted MHC binding and cross-conservation with self reveals patterns of viral camouflage (2014) (41)
Immunogenicity and immune modulatory effects of in silico predicted L. donovani candidate peptide vaccines (2012) (40)
T-Cell Dependent Immunogenicity of Protein Therapeutics Pre-clinical Assessment and Mitigation–Updated Consensus and Review 2020 (2020) (40)
H7N9 T-cell epitopes that mimic human sequences are less immunogenic and may induce Treg-mediated tolerance (2015) (38)
HCV epitope, homologous to multiple human protein sequences, induces a regulatory T cell response in infected patients. (2015) (38)
Tregitope: Immunomodulation powerhouse. (2014) (37)
Time for T? Immunoinformatics addresses vaccine design for neglected tropical and emerging infectious diseases (2014) (37)
Immune camouflage: Relevance to vaccines and human immunology (2014) (36)
Highly conserved influenza T cell epitopes induce broadly protective immunity. (2019) (36)
Human immunodeficiency virus reverse transcriptase T helper epitopes identified in mice and humans: correlation with a cytotoxic T cell epitope. (1991) (35)
Modulation of CD8+ T cell responses to AAV vectors with IgG-derived MHC class II epitopes (2013) (35)
Beyond humanization and de-immunization: tolerization as a method for reducing the immunogenicity of biologics (2013) (33)
Regulatory T cell epitopes (Tregitopes) in IgG induce tolerance in vivo and lack immunogenicity per se (2013) (33)
From immunome to vaccine: epitope mapping and vaccine design tools. (2003) (32)
In Vivo Validation of Predicted and Conserved T Cell Epitopes in a Swine Influenza Model (2016) (31)
Efficacy of novel plasmid DNA encoding vaccinia antigens in improving current smallpox vaccination strategy. (2006) (30)
A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines (2017) (30)
How the SARS vaccine effort can learn from HIV-speeding towards the future, learning from the past. (2003) (29)
T cell epitope redundancy: cross-conservation of the TCR face between pathogens and self and its implications for vaccines and autoimmunity (2016) (29)
Potential Application of Tregitopes as Immunomodulating Agents in Multiple Sclerosis (2011) (28)
Novel function of complement C3d as an autologous helper T‐cell target (2008) (27)
Knowledge, attitudes, practices and willingness to vaccinate in preparation for the introduction of HPV vaccines in Bamako, Mali (2017) (27)
Immunization with cross-conserved H1N1 influenza CD4+ T-cell epitopes lowers viral burden in HLA DR3 transgenic mice (2013) (26)
How the SARS vaccine effort can learn from HIV—speeding towards the future, learning from the past (2003) (25)
An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice (2017) (25)
Molecular epidemiology of HIV-1 infection in the Philippines, 1985 to 1997: transmission of subtypes B and E and potential emergence of subtypes C and F. (1998) (25)
Of [hamsters] and men (2012) (25)
Identification of genome-derived vaccine candidates conserved between human and mouse-adapted strains of H. pylori (2008) (24)
A Nurse-Run Walk-In Clinic: Cost-Effective Alternative to Non-urgent Emergency Department Use by the Uninsured (2013) (24)
Promiscuous Coxiella burnetii CD4 Epitope Clusters Associated With Human Recall Responses Are Candidates for a Novel T-Cell Targeted Multi-Epitope Q Fever Vaccine (2019) (24)
VaxCelerate II: Rapid development of a self-assembling vaccine for Lassa fever (2014) (23)
New tools, new approaches and new ideas for vaccine development (2007) (23)
Human Immune Responses to H. pylori HLA Class II Epitopes Identified by Immunoinformatic Methods (2014) (22)
Adeno-associated virus mediated delivery of Tregitope 167 ameliorates experimental colitis. (2012) (22)
Cross-conservation of T-cell epitopes: Now even more relevant to (H7N9) influenza vaccine design (2016) (22)
HIV-1 Vaccine Trials: Evolving Concepts and Designs (2012) (21)
Further progress on defining highly conserved immunogenic epitopes for a global HIV vaccine: HLA-A3-restricted GAIA vaccine epitopes (2012) (21)
Universal H1N1 influenza vaccine development (2013) (20)
Modelling the immunogenicity of therapeutic proteins using T cell epitope mapping. (2003) (20)
Peptide-pulsed dendritic cells induce the hepatitis C viral epitope-specific responses of naïve human T cells. (2014) (20)
Putting immunoinformatics to the test (2006) (20)
Immunogenic Consensus Sequence T helper Epitopes for a Pan-Burkholderia Biodefense Vaccine (2011) (20)
Tregitope Peptides: The Active Pharmaceutical Ingredient of IVIG? (2013) (19)
Vida Sana: A Lifestyle Intervention for Uninsured, Predominantly Spanish-Speaking Immigrants Improves Metabolic Syndrome Indicators (2015) (19)
Evolutionary deimmunization: an ancillary mechanism for self-tolerance? (2006) (19)
Immunome-derived vaccines (2004) (18)
Risks for HIV Infection in Incarcerated Women (1995) (18)
A Dominant EV71-Specific CD4+ T Cell Epitope Is Highly Conserved among Human Enteroviruses (2012) (18)
New approaches to enzyme replacement therapy for Pompe disease (2012) (17)
T cell epitope identification for bovine vaccines: an epitope mapping method for BoLA A-11. (2003) (17)
Development and validation of an epitope prediction tool for swine (PigMatrix) based on the pocket profile method (2015) (17)
Elevated antigen-specific Th2 type response is associated with the poor prognosis of hand, foot and mouth disease. (2013) (17)
Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation (2021) (16)
The role of glutamic or aspartic acid in position four of the epitope binding motif and thyrotropin receptor-extracellular domain epitope selection in Graves' disease. (2010) (16)
HIV infection among incarcerated women: epidemic behind bars. (2000) (16)
C3d adjuvant effects are mediated through the activation of C3d-specific autoreactive T cells (2014) (16)
Smarter vaccine design will circumvent regulatory T cell-mediated evasion in chronic HIV and HCV infection (2014) (16)
Making vaccines “on demand” (2013) (15)
In silico predictions; in vivo veritas (1999) (15)
Therapeutic administration of Tregitope-Human Albumin Fusion with Insulin Peptides to promote Antigen-Specific Adaptive Tolerance Induction (2019) (15)
T cell epitope content comparison (EpiCC) analysis demonstrates a bivalent PCV2 vaccine has greater T cell epitope overlap with field strains than monovalent PCV2 vaccines. (2020) (15)
Adherence to American Diabetes Association guidelines in a volunteer-run free clinic for the uninsured: better than standards achieved by clinics for insured patients. (2013) (14)
Harnessing the power of genomics and immunoinformatics to produce improved vaccines (2011) (14)
Preclinical development of HIvax: Human survivin highly immunogenic vaccines (2015) (14)
A comparison of two methods for T cell epitope mapping: “cell free” in vitro versus immunoinformatics (2011) (13)
"Tregitopes" Activation of natural regulatory T cells by IgG Fcderived peptide (2009) (13)
Immunome-derived vaccines (2004) (13)
In silico identification and modification of T cell epitopes in pertussis antigens associated with tolerance (2020) (12)
A prime-boost concept using a T-cell epitope-driven DNA vaccine followed by a whole virus vaccine effectively protected pigs in the pandemic H1N1 pig challenge model. (2019) (12)
HLA- and genotype-based risk assessment model to identify infantile onset pompe disease patients at high-risk of developing significant anti-drug antibodies (ADA). (2019) (12)
Report from the field (2012) (12)
Moving Helicobacter pylori vaccine development forward with bioinformatics and immunomics (2012) (12)
Prevalence of HPV 16 and 18 and attitudes toward HPV vaccination trials in patients with cervical cancer in Mali (2017) (12)
T‐cell epitope content comparison (EpiCC) of swine H1 influenza A virus hemagglutinin (2017) (11)
De-immunized and Functional Therapeutic (DeFT) versions of a long lasting recombinant alpha interferon for antiviral therapy. (2017) (11)
New vaccines needed for pathogens infecting animals and humans (2012) (11)
Immune escape and immune camouflage may reduce the efficacy of RTS,S vaccine in Malawi (2019) (11)
Health care access, utilization, and needs in a predominantly Latino immigrant community in Providence, Rhode Island. (2011) (11)
Dendritic Cell-Mediated, DNA-Based Vaccination against Hepatitis C Induces the Multi-Epitope-Specific Response of Humanized, HLA Transgenic Mice (2014) (11)
Cross-conservation of T-cell epitopes (2014) (11)
A replication-competent adenovirus assay for E1-deleted Ad35 vectors produced in PER.C6 cells. (2007) (10)
Tularemia vaccines - an overview. (2007) (10)
An immunoinformatic approach for identification of Trypanosoma cruzi HLA-A2-restricted CD8+ T cell epitopes (2015) (10)
Mass spectrometry-assisted identification of ADAMTS13-derived peptides presented on HLA-DR and HLA-DQ (2018) (10)
HPV knowledge and vaccine acceptance in an uninsured Hispanic population in Providence, RI. (2014) (9)
Epitope recognition in HLA-DR3 transgenic mice immunized to TSH-R protein or peptides. (2013) (9)
An Integrated Genomic and Immunoinformatic Approach to H. pylori Vaccine Design. (2011) (9)
Self-replicating RNAs drive protective anti-tumor T cell responses to neoantigen vaccine targets in a combinatorial approach. (2020) (9)
Computational vaccinology and the ICoVax 2012 workshop (2013) (8)
Tregitopes Improve Asthma by Promoting Highly Suppressive and Antigen-Specific Tregs (2021) (8)
Immunogenicity Screening Using in Silico Methods: Correlation between T‐Cell Epitope Content and Clinical Immunogenicity of Monoclonal Antibodies (2009) (8)
T cell epitope engineering: an avian H7N9 influenza vaccine strategy for pandemic preparedness and response (2018) (8)
Vaccine Informatics (2011) (7)
Multi-antigen Vaccination With Simultaneous Engagement of the OX40 Receptor Delays Malignant Mesothelioma Growth and Increases Survival in Animal Models (2019) (7)
Responding to COVID-19 in an Uninsured Hispanic/Latino Community: Testing, Education and Telehealth at a Free Clinic in Providence. (2020) (7)
Tools for Vaccine Design: Prediction and Validation of Highly Immunogenic and Conserved Class II Epitopes and Development of Epitope‐Driven Vaccines (2011) (7)
Coxiella burnetii Epitope-Specific T-Cell Responses in Patients with Chronic Q Fever (2019) (7)
Challenges and opportunities for HIV care in jails and prisons in the United States (2006) (7)
Immunogenicity of Therapeutic Fusion Proteins: Contributory Factors and Clinical Experience (2013) (7)
Analysis of ChimeriVax Japanese Encephalitis Virus envelope for T-cell epitopes and comparison to circulating strain sequences. (2007) (7)
Immune Tolerance-Adjusted Personalized Immunogenicity Prediction for Pompe Disease (2021) (7)
New Immunoinformatics Tools for Swine: Designing Epitope-Driven Vaccines, Predicting Vaccine Efficacy, and Making Vaccines on Demand (2020) (7)
Design of a multiepitopic Zaire ebolavirus protein and its expression in plant cells. (2019) (7)
The immune vulnerability landscape of the 2019 Novel Coronavirus, SARS-CoV-2 (2020) (7)
Teaching tolerance (2012) (7)
A Standard of HIV Care for Incarcerated Women: Northeastern United States' Experiences (1998) (7)
Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapy (2021) (7)
Use of Bioinformatics to Predict MHC Ligands and T-Cell Epitopes (2010) (6)
Co-infection with Mycobacterium tuberculosis and HIV in high risk clinical care setting in Rhode Island. (1998) (6)
Novel multiparameter correlates of Coxiella burnetii infection and vaccination identified by longitudinal deep immune profiling (2020) (6)
Agility in adversity: Vaccines on Demand (2016) (6)
Identification and retrospective validation of T-cell epitopes in the hepatitis C virus genotype 4 proteome (2014) (6)
Identification of a potent regulatory T cell epitope in factor V that modulates CD4+ and CD8+ memory T cell responses. (2021) (6)
Bridging the [Health Equity] Gap at a Free Clinic for Uninsured Residents of Rhode Island. (2018) (6)
HIV clinical trials in correctional settings: right or retrogression? (2001) (6)
Prevalence of Prior Sexual Abuse and HIV Risk-taking Behaviors in Incarcerated Women in Massachusetts (1995) (6)
Immunoinformatics: The Next Step in Vaccine Design (2010) (6)
HelicoVax: Epitope-based therapeutic H. pylori vaccination in a mouse model (2011) (6)
Barriers to Health Insurance Pre- and Post-Affordable Care Act Implementation in Providence, RI. (2015) (6)
Do Tregitopes have the potential to impact the current treatment landscape of autoimmune diseases (2013) (6)
Partial pathogen protection by tick-bite sensitization and epitope recognition in peptide-immunized HLA DR3 transgenic mice (2014) (6)
Exploring the immunome: A brave new world for human vaccine development (2009) (5)
Differential functional patterns of memory CD4+ and CD8+ T-cells from volunteers immunized with Ty21a typhoid vaccine observed using a recombinant Escherichia coli system expressing S. Typhi proteins. (2020) (5)
Building better biotherapeutics and vaccines by design: EpiVax, Inc., an immunology company. (2013) (5)
Suppression of CTL Responses against AAV-Capsid Epitopes by Peptide-Induced Regulatory T Cells. (2009) (5)
Clínica Esperanza/Hope Clinic clinical outcomes review: February-July 2011. (2011) (5)
A Novel Immunomodulator and Biomarker for Life-Threatening Diseases (5)
Time for T? Thoughts about the 2009 novel H1N1 influenza outbreak and the role of T cell epitopes in the next generation of influenza vaccines (2010) (5)
Use of bioinformatics to predict MHC ligands and T-cell epitopes: Application to epitope-driven vaccine design (2002) (5)
3 Prediction and Determination of MHC Ligands and T-cell Epitopes (1998) (4)
Immune-engineered H7N9 influenza hemagglutinin improves protection against viral influenza virus challenge (2020) (4)
Development of highly stable and de-immunized versions of recombinant alpha interferon: Promising candidates for the treatment of chronic and emerging viral diseases (2021) (4)
Immunoinformatics Applied to Modifying and Improving Biological Therapeutics (2008) (4)
Multi-step screening of neoantigens’ HLA- and TCR-interfaces improves prediction of survival (2021) (4)
Clinical trials in correctional settings: proceedings of a conference held in Providence, Rhode Island, October 13-15, 1999. (2000) (3)
Hit-and-run, hit-and-stay, and commensal bacteria present different peptide content when viewed from the perspective of the T cell. (2015) (3)
Do Tregitopes have the potential to impact the current treatment landscape of autoimmune diseases? (2013) (3)
Community clinic-based lifestyle change for prevention of metabolic syndrome: Rationale, design and methods of the ‘Vida Sana/healthy life’ program (2018) (3)
Development of a novel fully functional coagulation factor VIII with reduced immunogenicity utilizing an in silico prediction and deimmunization approach (2021) (3)
Immunogenicity of Teffector and Treg epitopes from H7N9 avian-origin influenza: impact of cross-reactivity with the human genome (VAC2P.934) (2014) (3)
Early Warning for Infectious Disease Outbreaks : A Q & A with Larry Madoff In Silico Vaccine Design : Accelerating the Response to BioThreats and Emerging Infectious Disease (2015) (3)
De-Immunization of Human Factor VIII: Identification of Epitopes in the C2 Domain (2008) (3)
Immunome-derived Epitope-driven Vaccines (ID-EDV) Protect against Viral or Bacterial Challenge in Humanized Mice (2009) (3)
Assessment of hypertension guidelines adherence at a free clinic serving a predominantly Latino population in Providence, RI. (2014) (2)
Universal H1N1 influenza vaccine development Universal H1N1 influenza vaccine development (2018) (2)
Identification and Immune Assessment of T Cell Epitopes in Five Plasmodium falciparum Blood Stage Antigens to Facilitate Vaccine Candidate Selection and Optimization (2021) (2)
Novel Methods for Addressing Immunogenicity of Therapeutic Enzymes (2015) (2)
Bridging Computational Vaccinology and Vaccine Development Through Systematic Identification, Characterization, and Downselection of Conserved and Variable Circumsporozoite Protein CD4 T Cell Epitopes From Diverse Plasmodium falciparum Strains (2021) (2)
In Silico Vaccine Design: Accelerating the Response to BioThreats and Emerging Infectious Disease (2015) (2)
Quantifying the Persistence of Vaccine-Related T Cell Epitopes in Circulating Swine Influenza A Strains from 2013–2017 (2021) (2)
Chapter 60 – Mycobacterium tuberculosis (2009) (2)
Progress towards a genome-derived, epitope-driven vaccine for latent TB infection. (2007) (2)
The measles campaign in West and Central Africa: remembering the future. (2008) (2)
T Cell Epitope Redundancy: Cross-conservation of the TCR face between Pathogens and Self and its Implications for Vaccines and Auto-immunity (2018) (2)
Place to be healthy: blueprint for a new free clinic for the medically uninsured of Rhode Island. (2008) (2)
Evidence implicating MHC genes in the immunological nonresponsiveness to the Plasmodium falciparum CS protein. (1990) (2)
Recruitment, Training, and Roles of the Bilingual, Bicultural Navegantes: Developing a Specialized Workforce of Community Health Workers to Serve a Low-Income, Spanish-Speaking Population in Rhode Island (2021) (2)
Computational vaccinology and the ICoVax 2012 workshop (2013) (1)
Design of T cell epitope-driven IAV vaccines for swine using immunoinformatics tools (VAC2P.929) (2014) (1)
A prediction model to identify infantile Pompe disease (IPD) patients at high-risk of developing significant anti-drug antibodies (ADA) utilizing acid α-glucosidase (GAA ) variants and HLA-type (2018) (1)
Publisher Correction: A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines (2017) (1)
Introduction to the Compendium (1998) (1)
Highly immunogenic vaccine for prevention and therapy of malignant mesothelioma (P4437) (2013) (1)
Shedding light on correctional HIV care. (2000) (1)
Meeting Gynecologic Needs and Assuring Adherence to Screening Guidelines at a Student-Run Free Clinic for Uninsured, Low-Income Women. (2022) (1)
Abstract 943: Filtering out self-like neoantigens improves immune response to cancer vaccines (2019) (1)
Antigen-specific tolerance induction by Tregitopes in vivo (P4202) (2013) (1)
VaxCelerate: the use of MTBhsp70-avidin as an adjuvant to rapidly generate self-assembling vaccines with biotinylated, antigen-specific peptides targeting emerging pathogens. (VAC6P.941) (2014) (1)
Tregitopes improve murine asthma by promoting highly suppressive and antigen specific Tregs (2020) (1)
Regulating immune responses to biologics: Epitope prediction and applications (58.23) (2012) (1)
Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation (2021) (1)
Integrated assessment of predicted MHC binding and cross-conservation with self reveals patterns of viral camouflage (2014) (1)
Immunogenic biologics: validation of screening, deimmunization and tolerization approaches (P3251) (2013) (1)
The need for compassionate care: HIV infection among incarcerated women. (1998) (1)
Evaluation of a Human T Cell-Targeted Multi-Epitope Vaccine for Q Fever in Animal Models of Coxiella burnetii Immunity (2022) (1)
Critical Prevention, Critical Care: Gynecological and Obstetrical Aspects of Comprehensive HIV Prevention and Treatment Among Incarcerated Women (1998) (1)
Expanding access to COVID-19 testing, vaccination and treatment at a free clinic for uninsured Spanish-speaking adults in Providence, RI (2022) (1)
Correction: A Dominant EV71-Specific CD4+ T Cell Epitope Is Highly Conserved among Human Enteroviruses (2014) (1)
Immunogenicity assessment of in silico-selected T cell epitopes for a burkholderia biodefense vaccine (P4282) (2013) (1)
Novel function of complement C3d as an autologous helper T cell target (2008) (1)
IgG-Derived Tregitope Peptides Suppress T Cell Responses in Vitro and in Vivo (2008) (1)
Leukocyte Antigen-DR Molecules in Graves' Disease Thyrotropin Receptor Epitopes and Their Relation to Histocompatibility (2006) (1)
Four Years of CHEER: Cost and QALY Savings of a Free Nurse-run Walk-in Clinic Serving an Uninsured, Predominantly Spanish-speaking Immigrant Population in Providence (2019) (1)
Human antibody immune responses are personalized by selective removal of MHC-II peptide epitopes (2021) (1)
Preclinical design of less immunogenic biologics: Tregitopes and Tolerance (144.28) (2010) (1)
Coxiella burnetii epitope-specific T-cell responses in chronic Q fever patients (2019) (0)
Novel H7N9 influenza immunogen design enhances mobilization of seasonal influenza T cell memory in H3N2 pre-immune mice (2022) (0)
Identification of a Tolerogenic Factor V Peptide and Its Potential Role in FVIII Tolerance Induction (2017) (0)
Moving H. pylori Vaccine Development Forward with Bioinformatics and Immunomics (2016) (0)
ICoVax 2013: The 3rd ISV Pre-conference Computational Vaccinology Workshop (2014) (0)
8th vaccine renaissance: A creative nexus for vaccine developers (2015) (0)
Co-chief Editors Deputy Editors Hiv Infection among W Omen in P Rison : C Onsiderations for C Are (2005) (0)
Regulatory T cell epitopes (Tregitopes) in IgG induce tolerance in vivo and lack immunogenicity per (2018) (0)
HEPP News, Vol. 3 No. 1 (2016) (0)
The role of viral genetic variability in HIV-associated neurocognitive disorder. (2009) (0)
Clinical outcomes of a community clinic-based lifestyle change program for prevention and management of metabolic syndrome: Results of the ‘Vida Sana/Healthy Life’ program (2021) (0)
Species neutral correlates of immunogenicity for vaccines and protein therapeutics: Fact or Science Fiction (2010) (0)
Identification, Selection and Immune Assessment of Liver Stage CD8 T Cell Epitopes From Plasmodium falciparum (2021) (0)
Epitope analysis confirms a bivalent PCV2 vaccine is relevant to the diversity of current, global strains (0)
T-cell epitope content comparison ( EpiCC ) of swine H 1 influenza A virus hemagglutinin (2019) (0)
ICoVax 2013: The 3rd ISV Pre-conference Computational Vaccinology Workshop (2014) (0)
Review of Bioinformatics for Vaccinology by Darren R. Flower, Ph.D. (2010) (0)
A story-telling cloth approach to motivating cervical cancer screening in Mali (2022) (0)
Tregitope-mediated antigen-specific tolerance induction in autoimmune and allergic disease in vivo. (THER5P.831) (2014) (0)
AMethod for Individualizing the Prediction of Immunogenicity of Protein Vaccines and Biologic Therapeutics : Individualized T Cell EpitopeMeasure ( iTEM ) (2014) (0)
Abstract B089: Application of precision cancer immunotherapy design tools to bladder cancer: Non-self-like neoepitopes as a prognostic biomarker (2019) (0)
Abstract 5311: Integrated approaches for design of precision cancer immunotherapies: Selection of Class I and Class II T cell neo-epitopes and removal of Treg epitopes (2018) (0)
Reducing Protein Immunogenicity by Design: Deimmunization and Tolerance Induction (2012) (0)
100 Tumor homology with self as a biomarker for response to checkpoint inhibitor therapy (2022) (0)
Improved GAA activity in tregitope-treated pompe disease: preclinical studies (TECH1P.864) (2014) (0)
Women in Prison : The Impact of HIV (2016) (0)
Legacy of light for women living with HIV in prison Breaking the Walls of Silence 1999 Overlook Press New York 0-87951-500-7 The Members of the ACE (AIDS Counseling and Education) Program of the Bedford Hills Correctional Facility. Pp 336. $29.95.1998 (1999) (0)
Diversity and evolution of computationally predicted T cell epitopes against human respiratory syncytial virus (2022) (0)
In silico Prediction of Immunogenic T Cell Epitopes of Leishmania donovani donovani GP 63 Protein : an Alternative Approach for Anti-parasite Vaccine Development (2015) (0)
European Immunogenicity Platform 11th Open Scientific Symposium on immunogenicity of biopharmaceuticals. (2020) (0)
HEPP News, Vol. 2 No. 4 (2016) (0)
Immunoinformatic analysis of Chinese hamster ovary (CHO) protein contaminants in therapeutic protein formulations (2012) (0)
Sa1874 Selection, Identification and Validation of a Panel of Immunogenic H. pylori Peptides (2013) (0)
Expression strategies for the tumor inhibitor, human angiostatin in tobacco (2001) (0)
Fifth Vaccine Renaissance introduction. (2012) (0)
IDCR: Infectious Diseases in Corrections Report, Vol. 8 No. 5/6 (2016) (0)
HIV-1 Infection Functional Flexibility in HIV-2 Compared to TCR Heterogeneity and + Greater CD8 (2003) (0)
Current HIV Antiretrovirals and Dosages . * (2016) (0)
iVAX: a sophisticated suite of online vaccine design tools (P3269) (2013) (0)
Fifth Vaccine Renaissance introduction (2012) (0)
Specific sequence mutations in a long-lasting rhIFN-α2b version reduce in vitro and in vivo immunogenicity and increase in vitro protein stability. (2023) (0)
Quantifying quality of care at a PA student-led free diabetes clinic. (2020) (0)
Cross-reactive influenza H1N1 T cell epitopes identified by immunoinformatic methods stimulate CD4+ T cell responses (P4303) (2013) (0)
H1N1 G4 swine influenza T cell epitope analysis in swine and human vaccines and circulating strains uncovers potential risk to swine and humans (2022) (0)
Vaccine renaissance--from basic research to implementation. (2007) (0)
Learning from the past, planning for the future--DOT for HIV infection. (2002) (0)
Women incest survivors in prison. An open letter from a prison doctor to those who care for women living with HIV. (2001) (0)
Mutations in Spike Gene of SARS-CoV-2 that Are Associated with a Higher Viral Load: A Clinical Case Study (2022) (0)
Tregitopes: The active ingredient in IVIG-mediated tolerance induction? (P5224) (2013) (0)
Accelerated development of a T Cell epitope-driven biodefense vaccine for Burkholderia (VAC7P.957) (2014) (0)
Ask the Expert : A New Infection with an Undetectable Viral Load 6 (2001) (0)
Tregitope mechanism of action and applications for tolerance induction. (116.8) (2012) (0)
Immunoinformatic approach to a multi-pathogen genome-derived epitope-driven vaccine (2010) (0)
STEALTHIER MUTANOMES ARE INDUCED AFTER NIVOLUMAB IMMUNOTHERAPY (2021) (0)
Su.76. High Throughput Validation of Predicted T-Cell Epitopes in F. Tularensis: the Development of a Novel T-Cell Epitope Based Tularemia Vaccine (2006) (0)
Immune engineering enhances H7N9 vaccine immunogenicity by regulatory T cell epitope deletion in hemagglutinin (2016) (0)
Review of Bioinformatics for Vaccinology by Darren R. Flower, Ph.D. (2010) (0)
The Sir Mark Oliphant Conferences: International frontiers of science and technology (2008) (0)
In Vitro and In Vivo Studies of IgG-derived Treg Epitopes (Tregitopes): A Promising New Tool for Tolerance Induction and Treatment of Autoimmunity (2012) (0)
Immunoinformatic discovery of potential cross-reactive T cell epitopes in the measles genome (2011) (0)
3 Immunogenicity of H. pylori's CagA-Derived Peptides for Future Vaccine Development (2016) (0)
1-1-2019 Multi-antigen Vaccination With Simultaneous Engagement of the OX 40 Receptor Delays Malignant Mesothelioma Growth and Increases Survival in Animal Models (2019) (0)
Immune Profiling of Coxiella burnetii Infection by Mass Cytometry (2016) (0)
Predicting tolerance in vaccine antigens: Application to influenza, HCV and HIV (2016) (0)
Su.88. High Throughput Validation of Predicted T-Cell Epitopes Conserved Between Variola and Vaccinia: Development of a Novel Immunome Based Smallpox Vaccine (2006) (0)
Coagulation Factor VIII with Reduced Immunogenicity via a Direct De-immunization Approach (2019) (0)
Editorial comment: HIV testing in prisons and jails--providing the carrot with the stick. (2007) (0)
A Novel Model of IVIG Immunosuppression: Activation of Natural Regulatory T cells by IgG‐Derived Peptides (2008) (0)
313 Stealthier mutanomes are induced after nivolumab immunotherapy (2021) (0)
Highly cross-conserved burkholderia T cell epitopes generate effector T cell responses in vitro (2016) (0)
Development and validation of an epitope prediction tool for swine (PigMatrix) based on the pocket profile method (2015) (0)
Exploit T cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines (2020) (0)
Tregitope applications to tolerance induction in autoimmune diseases. (116.10) (2012) (0)
Abstract 4540: MiVax: an innovative cancer neoantigen prediction system (2017) (0)
Immunoinformatic-driven H. pylori vaccine design (2010) (0)
Publisher Correction: A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines (2019) (0)
Abstract A018: High-value T cell epitope selection for mutanome-directed cancer immunotherapy using an innovative cancer neo-epitope classification system (2016) (0)
58 Excluding treg epitopes and integrating CD8 and CD4 effector neoepitope content improves prognostic biomarker tool in bladder cancer (2020) (0)
Innovation, urgency and acceptance at the 9th Vaccine Renaissance (2016) (0)
Mo2010 Aav5 Mediated Delivery of Regulatory T-Cell Epitope 167 Ameliorates Acute Experimental Colitis and Prevents a Type 1 Hypersensitivity Reaction in a TNBS Model of Crohn's Disease (2012) (0)
In silico immunogenicity assessment for sequences containing unnatural amino acids: A method using existing in silico algorithm infrastructure and a vision for future enhancements (2022) (0)
Prediction of T cell Epitopes for HIV Vaccine Development by Computer-driven Algorithm (1995) (0)
Su1829 BIoinformatic Approach to Mapping Global H. pylori cagA Sequences for Targeted Vaccine Development (2015) (0)
Alarming statistics about incarcerated women. (2001) (0)

This paper list is powered by the following services:

Other Resources About Anne Searls De Groot

en.wikipedia.org

What Schools Are Affiliated With Anne Searls De Groot?

Anne Searls De Groot is affiliated with the following schools:

Anne Searls De Groot's Academic­Influence.com Rankings